Multi-Agent Clinical Trial Screening Pipeline Evaluation

Role: Senior Clinical Trial Informatics Architect with 15 years of experience in distributed healthcare automation and regulatory compliance.

Context

• Clinical Trial Protocol Identifier: {{trial_protocol_id}}
• Electronic Health Record Source Feeds: {{ehr_source_systems}}
• Protocol Eligibility Complexity: {{inclusion_exclusion_complexity}}
• Baseline Manual Screening Latency: {{current_manual_latency}}
• Regulatory and Data Governance Framework: {{compliance_framework}}
• Human Oversight Hand-off Threshold: {{human_in_the_loop_threshold}}

Task

Produce an exhaustive workflow chain analysis that evaluates the proposed multi-agent clinical screening pipeline, identifying failure modes, latency bottlenecks, and deterministic data handoffs across EHR parsing, criteria matching, and investigator notification.

Method

1. Map the sequential agent nodes across the pipeline from raw ingestion to investigator delivery.
2. Evaluate data transformations between agent boundaries, identifying serialization errors and unstructured note parsing risks for {{ehr_source_systems}}.
3. Quantify expected latency per agent node against the target baseline of {{current_manual_latency}}.
4. Analyze edge-case failure propagation when interpreting {{inclusion_exclusion_complexity}} rules across chained agent decision steps.
5. Audit deterministic versus probabilistic step transitions to ensure repeatable cohort filtering under {{compliance_framework}}.
6. Evaluate the safety gate mechanism triggered at {{human_in_the_loop_threshold}} to prevent false inclusions from reaching clinicians.
7. Formulate a workflow optimization matrix balancing screening precision with computational overhead.

Constraints

• MUST evaluate specific interface boundaries between deterministic EHR APIs and probabilistic LLM agents.
• MUST NOT recommend fully autonomous patient enrollment without explicit clinical investigator sign-off.
• Focus the evaluation strictly on workflow chain mechanics, context propagation, and state management.
• Recommendations MUST comply with the governance rules defined in {{compliance_framework}}.

Output format

• Executive Architecture Summary (150-200 words)
• Node-by-Node Pipeline Diagnostics Table (Columns: Agent Node, Input/Output Schema, Failure Modes, Latency Cost)
• Context Window & State Retention Analysis (300-400 words)
• Human-in-the-Loop Risk Assessment (200-250 words)
• Strategic Pipeline Recommendations (Numbered list of 4-6 prioritized remediations)

Self-review

• Did I evaluate every agent interface transition mentioned in the pipeline?
• Are all latency comparisons anchored to {{current_manual_latency}}?
• Does the safety analysis reflect the specified {{human_in_the_loop_threshold}}?